Aug 28, 2015 - I want to provide investors a live look at my portfolio management practices during periods of significant volatility.
Aug 28, 2015 - Veeva Systems Inc. (VEEV) reported adjusted earnings of 10 cents per share in the second quarter of fiscal 2016, in line with the Zacks Consensus Estimate
Aug 28, 2015 - I will be holding an expert discussion panel on Geron today.
Aug 27, 2015 - TiGenix's pivotal Phase 3 trial in Europe met its primary endpoint in an indication targeting a potential $2 billion orphan market.
Aug 27, 2015 - Glaxo stock has declined due to patent expirations and negative investor sentiment, which offers opportunistic investors a reasonable buying opportunity.
Aug 27, 2015 - This article discusses latest advances in chronic lymphocytic leukemia.
Aug 27, 2015 - 30 top business sector-leading stocks ranked themselves by yield from 5.73% to 43.05% as of August 24.
Aug 26, 2015 - Novartis (NVS) with partner Ligand (LGND) announced that the FDA has approved the use of Promacta in children between 1 to 6 years of age with chronic ITP.
Aug 25, 2015 - This article discusses Valeant and EP Vantage's take on it.
Aug 24, 2015 - Novartis (NVS) inked a deal with GlaxoSmithKline to acquire all remaining rights to Arzerra for up to $1 billion plus royalties.